FindTrial
Sign In

Study on Predicting the Efficacy of Radiotherapy and Chemotherapy for Lung Squamous Cell Carcinoma Using Lung Cancer Bionic Organoids

Study on Predicting the Efficacy of Radiotherapy and Chemotherapy for Lung Squamous Cell Carcinoma Using Lung Cancer Bionic Organoids

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110795
Enrollment
Unknown
Registered
2025-10-21
Start date
2025-10-25
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced squamous lung cancer

Interventions

Follow-up group:none

Sponsors

The First People’s Hospital of Jingzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients with locally advanced squamous cell lung cancer who have undergone radical chemoradiotherapy due to inoperability;

Exclusion criteria

Exclusion criteria: 1.none;

Design outcomes

Primary

MeasureTime frame
Progression-free survival;Overall survival;—

Countries

China

Contacts

Public ContactZenghai

The First People’s Hospital of Jingzhou

zenghai0716@163.com+86 181 6313 7530

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026